23.88
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45 - marketscreener.com
Amphastar (AMPH) Faces Downgrade Amid Pipeline Challenges | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals, Comstock, Range Resources - TradingView
Amphastar Pharmaceuticals: Navigating Through An Inflection Year (NASDAQ:AMPH) - Seeking Alpha
Schonfeld Strategic Advisors LLC Acquires 33,007 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Trend Tracker for (AMPH) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Raises Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
U.S. Naloxone Market to Witness Remarkable Growth with Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc. - openPR.com
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - ACCESS Newswire
U.S. Naloxone Market Set to Witness Significant Growth - openPR.com
First Trust Advisors LP Acquires 63,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals’ Mixed Earnings Call Insights - TipRanks
43,235 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Aristeia Capital L.L.C. - MarketBeat
Amphastar Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Amphastar (AMPH) Target Price Slashed by Wells Fargo Analyst | A - GuruFocus
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2025 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Revenue Miss: EPS Exceeds ExpectationsNews and Statistics - IndexBox
Amphastar Pharmaceuticals Reports Q1 2025 Earnings - TipRanks
Amphastar: Q1 Earnings Snapshot - The Washington Post
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales Targets - Yahoo Finance
Earnings call transcript: Amphastar Q1 2025 misses earnings, stock edges up - Investing.com Australia
Amphastar Q2 2025 slides: strategic shift to proprietary drugs amid growth challenges - Investing.com India
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - ACCESS Newswire
Earnings Flash (AMPH) Amphastar Pharmaceuticals Posts Q1 Adjusted EPS $0.74, vs. FactSet Est of $0.69 - marketscreener.com
Amphastar Pharmaceuticals (AMPH) Expected to Announce Earnings on Wednesday - MarketBeat
Earnings Outlook For Amphastar Pharma - Nasdaq
Amphastar Pharmaceuticals to Announce Earnings: What to ExpectNews and Statistics - IndexBox
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Insider Sell: Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH) - GuruFocus
Raymond James Financial Inc. Acquires Shares of 92,904 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - MSN
Take off with Amphastar Pharmaceuticals Inc (AMPH): Get ready for trading - Sete News
Adversity is less terrifying than hope: Inovio Pharmaceuticals Inc (INO) - Sete News
Envestnet Asset Management Inc. Sells 2,463 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025 - Yahoo Finance
Barclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Oberweis Asset Management Inc. - MarketBeat
Learn to Evaluate (AMPH) using the Charts - news.stocktradersdaily.com
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of - The Globe and Mail
Anaphylaxis Treatment Market Size in 7MM is expected to grow at - openPR.com
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):